NEW YORK, Dec. 15, 2017 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synergy Pharmaceuticals, Inc. (“Synergy” or the “Company”) (NASDAQ: SGYP).
If you invested in Synergy stock or options between September…
